BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4153596)

  • 1. Clozapine and haloperidol in a single-blind cross-over trial: therapeutic and biochemical aspects in the treatment of schizophrenia.
    Gerlach J; Koppelhus P; Helweg E; Monrad A
    Acta Psychiatr Scand; 1974; 50(4):410-24. PubMed ID: 4153596
    [No Abstract]   [Full Text] [Related]  

  • 2. Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients.
    Gerlach J; Thorsen K; Fog R
    Psychopharmacologia; 1975; 40(4):341-50. PubMed ID: 1096218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Our experience with clozapine treatment.
    Molcan J; Novotný V; Schulpková L
    Act Nerv Super (Praha); 1974 Aug; 16(3):200-1. PubMed ID: 4153762
    [No Abstract]   [Full Text] [Related]  

  • 4. Further clinical and EEG experience with clozapine.
    Náhunek K; Svestka J; Rodová A; Misurec J
    Act Nerv Super (Praha); 1974 Aug; 16(3):202-3. PubMed ID: 4153786
    [No Abstract]   [Full Text] [Related]  

  • 5. Clozapine (Leponex) compared with chlorpromazine: a double-blind evaluation of pharmacological and clinical properties.
    Ekblom B; Haggstrom JE
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):945-57. PubMed ID: 4154183
    [No Abstract]   [Full Text] [Related]  

  • 6. Some methodological considerations for the clinical evaluation of neuroleptics--comparative effects of clozapine and haloperidol on schizophrenics.
    Itoh H; Miura S; Yagi G; Sakurai S; Ohtsuka N
    Folia Psychiatr Neurol Jpn; 1977; 31(1):17-24. PubMed ID: 863344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic efficacy of clozapine in correlation to changes in catecholamine metabolism in man.
    Ackenheil M; Beckmann H; Greil W; Hoffmann G; Markianos E; Raese J
    Adv Biochem Psychopharmacol; 1974; 9(0):647-57. PubMed ID: 4836227
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience with clozapine in psychoses.
    Zapletálek M; Pazdírek S; Hübsch T; Strnad D
    Act Nerv Super (Praha); 1974 Aug; 16(3):203-4. PubMed ID: 4153798
    [No Abstract]   [Full Text] [Related]  

  • 9. [Double-blind clinical study of HF 1854 (LX 100-129, clozapine or leponex) as compared with haloperidol].
    Ciurezu T; Ionescu R; Nica Udangiu S; Niţurad D; Oproiu L; Tudorache D; Popovici I; Curelaru S
    Neurol Psychiatr (Bucur); 1976; 14(1):29-34. PubMed ID: 788132
    [No Abstract]   [Full Text] [Related]  

  • 10. Clozapine--a potential antipsychotic agent without extrapyramidal manifestations.
    Matz R; Rick W; Thompson H; Gershon S
    Curr Ther Res Clin Exp; 1974 Jul; 16(7):687-95. PubMed ID: 4210458
    [No Abstract]   [Full Text] [Related]  

  • 11. A crossover study of clocapramine and haloperidol in chronic schizophrenia.
    Yamagami S
    J Int Med Res; 1985; 13(6):301-10. PubMed ID: 4076529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
    Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A;
    J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
    Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M
    Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multifocal psychopharmaceutic testing ("Multihospital trial")].
    Fischer-Cornelssen K; Ferner U; Steiner H
    Arzneimittelforschung; 1974 Oct; 24(10):1706-24. PubMed ID: 4154763
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacological and neurochemical effects of clozapine (Leponex): new aspects in the drug therapy of schizophrenia].
    Bürki HR; Ruch W; Asper H; Baggiolini M; Stille G
    Schweiz Med Wochenschr; 1973 Dec; 103(48):1716-24. PubMed ID: 4753069
    [No Abstract]   [Full Text] [Related]  

  • 16. [Value of neuroleptic therapy in the self assessment of schizophrenic patients].
    Heim M
    Psychiatr Neurol Med Psychol (Leipz); 1987 Aug; 39(8):487-91. PubMed ID: 3685210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind comparison of pimozide with carpipramine in schizophrenic patients.
    Kudo Y
    Acta Psychiatr Belg; 1972 Nov; 72(6):685-97. PubMed ID: 4606115
    [No Abstract]   [Full Text] [Related]  

  • 18. Clozapine in China: a review and preview of US/PRC collaboration.
    Potter WZ; Ko GN; Zhang LD; Yan WW
    Psychopharmacology (Berl); 1989; 99 Suppl():S87-91. PubMed ID: 2682733
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder.
    Miceli JJ; Tensfeldt TG; Shiovitz T; Anziano RJ; O'Gorman C; Harrigan RH
    Clin Ther; 2010 Mar; 32(3):472-91. PubMed ID: 20399985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol.
    Andrezina R; Josiassen RC; Marcus RN; Oren DA; Manos G; Stock E; Carson WH; Iwamoto T
    Psychopharmacology (Berl); 2006 Oct; 188(3):281-92. PubMed ID: 16953381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.